Yili Chuanning Biotechnology Co.,Ltd. (SHE:301301)
China
· Delayed Price · Currency is CNY 10.34
+0.06 (0.58%)
At close: Dec 5, 2025
SHE:301301 Revenue
Yili Chuanning Biotechnology had revenue of 1.09B CNY in the quarter ending September 30, 2025, a decrease of -13.76%. This brings the company's revenue in the last twelve months to 4.74B, down -16.85% year-over-year. In the year 2024, Yili Chuanning Biotechnology had annual revenue of 5.76B with 19.38% growth.
Revenue (ttm)
4.74B
Revenue Growth
-16.85%
P/S Ratio
4.87
Revenue / Employee
1.49M
Employees
3,184
Market Cap
23.06B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jiangsu Hengrui Pharmaceuticals Co.,Ltd | 30.98B |
| WuXi AppTec | 43.88B |
| Shenzhen Mindray Bio-Medical Electronics | 33.07B |
| Sichuan Biokin Pharmaceutical | 2.23B |
| Shanghai United Imaging Healthcare | 12.20B |
| Aier Eye Hospital Group | 22.17B |
| Zhangzhou Pientzehuang Pharmaceutical., | 9.78B |
| Yunnan Baiyao Group Co.,Ltd | 40.77B |